Much of the research into treatment has been done at the St. Louis
University Liver Center, one of the busiest liver-disease practices in
the nation. More than 1,000 visits are made to the center each year.
at the center were involved in testing a drug combination approved by
the FDA over one year ago that increased the cure rate of hepatitis C by
half or more. They are currently testing more effective regimens with
fewer side effects that are expected to become available within two